Close Menu

NEW YORK (GenomeWeb) – Curetis said today that it is planning a €4.1 million ($5.0 million) equity offering and that it has secured a $10 million equity facility with a New York-based venture capital firm.

According to Curetis, it has received commitments from qualified investors in the US and Europe to purchase 854,166 newly issued shares at €4.80 each. The equity facility will allow the company to raise up to $10 million in additional equity — solely at its request — from Global Corporate Finance over a 36-month period.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Sponsored by
LGC SeraCare Life Sciences

Non-invasive prenatal testing (NIPT) continues to expand globally to support maternal-fetal patient care. 

Sponsored by

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.